Bespak is increasing pressurized metered dose inhaler manufacturing capacity to support Chiesi Group’s Carbon Minimal Inhaler (CMI) program.

XCells Biotechnologies USA Inc. has delivered over 500 characterized induced pluripotent stem cell lines as part of a multi-year collaboration with a global biotechnology company.

New biosimilar development, manufacturing and supply unit will be headed by Armin Metzger.

Lundbeck has named Markus Kede Senior Vice President and Chief AI Officer. He is currently SVP, Finance & Business Planning for Lundbeck US.

NewcelX Ltd., a clinical-stage company, has entered a strategic collaboration with Eledon Pharmaceuticals Inc., a ...

New Annex 1–compliant filling line expands eye care production in Italy; additional systems planned for U.S. facilities.

Nina Bauer of FUJIFILM Cellular Dynamics shares insight on addressing challenges and supporting developers heading towards commercialization.

Sotyktu (deucravacitinib) for treatment of adults with active psoriatic arthritis (PsA). Sotyktu is an oral, selective ...

Will expand manufacturing capacity at Lonza’s Houston facility to support growing demand for Genetix’s ZYNTEGLO ...

“Partnering with Demeetra strengthens our ability to support biotech companies with a rapid and reliable path to GMP material ...

Spruce Biosciences Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for ...

Novo Nordisk has signed an agreement with Hims & Hers Health that will allow the telehealth provider to offer FDA‑approved versions of Ozempic and Wegovy at self‑pay prices comparable to other digital ...